Tasly Pharmaceutical Group Co., Ltd (600535.SS) SHH
14.13
-0.21(-1.46%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 22.51B |
| Enterprise Value | 22.56B |
| P/E Ratio | 18.15 |
| PEG Ratio | 0.91 |
| Price/Sales Ratio | 2.53 |
| Price/Book Ratio | 1.65 |
| Enterprise/Revenue | 2.6 |
| Enterprise/EBITDA | 12.98 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.14 |
| Operating Margin | 0.17 |
Management Effectiveness
| Return On Assets | 0.07 |
| Return On Equity | 0.09 |
Income Statement
| Revenue | 8.24B |
| Revenue/Share | 5.59 |
| Gross Profit | 5.51B |
| EBITDA | 1.74B |
| Net Income | 1.11B |
| Diluted EPS | 0.74 |
Balance Sheet
| Total Cash | 2.46B |
| Total Cash/Share | 1.65 |
| Total Debt | 1.23B |
| Total Debt/Equity | 0.1 |
| Current Ratio | 3.72 |
| Book Value Per Share | 8.64 |
Price History
| 52-Week Change | -15.66 |
| 52-Week High | 17.69 |
| 52-Week Low | 13.45 |
| Moving Average 50 Days | 14.44 |
| Moving Average 200 Days | 15.1 |
Statistics
| Average Volume | 10.17M |
| Shares Outstanding | 1.49B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.31 |
| Trailing Annual Dividend Yield | 2.2 |
| Payout Ratio | 0.28 |
| Last Split Factor | 7:5 |
| Last Split Date | June 05, 2018 |
